A Strategic Approach to Positioning of Cytochrome P450 Studies and Risk Assessment for Drug-Drug Interaction in Drug Discovery

被引：0
|
作者：
Yasuhiro, Yamada [1 ]
机构：
[1] Mitsubishi Tanabe Pharma Corp, DMPK Res Lab, Toda, Saitama 3358505, Japan
来源：
16TH INTERNATIONAL CONFERENCE ON CYTOCHROME P450, PROCEEDINGS | 2009年
关键词：
D O I：
暂无
中图分类号：
TQ [化学工业];
学科分类号：
0817 ;
摘要：
引用
收藏
页码：7 / 11
页数：5
相关论文
共 50 条
  • [21] In Silico Prediction of Drug-Drug Interactions Mediated by Cytochrome P450 Isoforms
    Dmitriev, Alexander V.
    Rudik, Anastassia V.
    Karasev, Dmitry A.
    Pogodin, Pavel V.
    Lagunin, Alexey A.
    Filimonov, Dmitry A.
    Poroikov, Vladimir V.
    PHARMACEUTICS, 2021, 13 (04)
  • [22] Evaluation of the Cytochrome P450 3A and P-glycoprotein Drug-Drug Interaction Potential of Futibatinib
    Yamamiya, Ikuo
    Hunt, Allen
    Takenaka, Toru
    Sonnichsen, Daryl
    Mina, Mark
    He, Yaohua
    Benhadji, Karim A.
    Gao, Ling
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (10): : 966 - 978
  • [23] Protein family based approach in drug discovery: cytochrome P450
    Gilep, A. A.
    Usanov, S. A.
    Strushkevich, N., V
    JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2018, 50 (06) : 504 - 504
  • [24] Current Cytochrome P450 Phenotyping Methods Applied to Metabolic Drug-Drug Interaction Prediction in Dogs
    Mills, Beth Miskimins
    Zaya, Matthew J.
    Walters, Rodney R.
    Feenstra, Kenneth L.
    White, Julie A.
    Gagne, Jason
    Locuson, Charles W.
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (03) : 396 - 404
  • [25] Potential Cytochrome P450 Drug-Drug Interaction Among Adult and Adolescent Patients Undergoing Tonsillectomy
    Nimmagadda, Sai
    Wong, Stephanie Jung-ying
    Faria, Madlin
    Allen, Paul
    Faria, John
    OTO OPEN, 2020, 4 (02)
  • [26] GENERATION AND USE OF MULTIPLE CYTOCHROME P450 HUMANIZED AND KNOCKOUT MOUSE MODELS FOR DRUG-DRUG INTERACTION, PHARMACOKINETIC AND SAFETY STUDIES
    Scheer, Nico
    Kapelyukh, Yury
    McLaughlin, Lesley A.
    McMahon, Mike
    Rode, Anja
    Henderson, Colin
    Wolf, C. Roland
    DRUG METABOLISM REVIEWS, 2014, 45 : 91 - 92
  • [27] Value of Assessing 1-Hydroxymidazolam in Drug-Drug Interaction Studies with Midazolam as a Substrate of Cytochrome P450 3A
    Magliocca, Massimo
    Berger, Benjamin
    Lemoine, Vincent
    Kaufmann, Priska
    Dingemanse, Jasper
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (09): : 1123 - 1129
  • [28] A Novel PBPK Modeling Approach to Assess Cytochrome P450 Mediated Drug-Drug Interaction Potential of the Cytotoxic Prodrug Evofosfamide
    Luepfert, Christian
    Dyroff, Martin
    von Richter, Oliver
    Gallemann, Dieter
    El Bawab, Samer
    Dolgos, Hugues
    Jung, Don
    Hecht, Stefan
    Johne, Andreas
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2018, 7 (12): : 829 - 837
  • [29] Antiplatelet Drug Resistance and Drug-Drug Interactions: Role of Cytochrome P450 3A4
    Wei C. Lau
    Paul A. Gurbel
    Pharmaceutical Research, 2006, 23 : 2691 - 2708
  • [30] Antiplatelet drug resistance and drug-drug interactions: Role of cytochrome p450 3A4
    Lau, Wei C.
    Gurbel, Paul A.
    PHARMACEUTICAL RESEARCH, 2006, 23 (12) : 2691 - 2708
12345